Home›Companies›Healthcare›Eyenuk

Eyenuk, Inc.

AI eye-screening software helps healthcare providers detect diabetic retinopathy.

Updated Nov 10, 2026·Latest SEC filing Jun 22, 2026·Suggest an edit

About Eyenuk

Eyenuk is a private company based in Woodland Hills, California. It has reported $33,889,587 raised in five offerings on Form D since July 2016. Its chief executive is Gaurav Agarwal.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 28, 2026Jun 22, 2026$5,607,046of $5.6M target12$467KEquityRule 506(b)Form D ↗
Aug 3, 2022Aug 23, 2022$22,428,831of $26.9M target27$830KEquityRule 506(b)Form D ↗
Apr 27, 2018May 1, 2018$3,000,000of $4.0M target6$500KEquityRule 506(b)Form D ↗
Oct 18, 2017Nov 1, 2017$1,353,710of $2.0M target8$169KEquityRule 506(b)Form D ↗
Jul 7, 2016Jul 21, 2016$1,500,000of $2.2M target7$214KEquityRule 506(b)Form D ↗
Total, five offerings$33,889,587

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Eyenuk's Form D filed Jun 22, 2026.

GA
Gaurav Agarwal
Chief Executive Officer and director
Mads Dall
Mads Dall
Chairman of the Board

Earlier filings also listed Robert Binney (director, last listed Aug 2022), Manish Potti (director, last listed Aug 2022), Frank Cheng (executive officer, last listed Aug 2022) and Martin Coyne (director, last listed May 2018).

Sources

  1. SECEyenuk, Inc. filing history
  2. CompanyEyenuk contact
  3. CompanyAbout Eyenuk
  4. PressEyeArt FDA clearance announcement